Exclusive: Global Vaccine Alliance Denies Reports It Has Decided to End Free COVID Vaccines for 37 Middle Income Nations 09/12/2022 Stefan Anderson & Elaine Ruth Fletcher Gavi, the Vaccine Alliance, has pushed back on media reports that its board has decided to end COVID vaccine support for 37 middle-income countries next year – and end altogether the dedicated COVAX vaccine facility, supplying free vaccines to some 92 low- and middle-income countries, in 2024. A high-ranking official at Gavi told Health Policy […] Continue reading -> South Korea Becomes First Country to Achieve Highest Level in WHO’s Medicine And Vaccine Regulatory Assessment 01/12/2022 Megha Kaveri South Korea became the first country in the world to achieve the highest level, “maturity level 4” (ML4), in regulating medicines and vaccines. The Ministry of Food and Drug Safety (MFDS) in the Republic of Korea is the only national regulatory authority to be recognised by the World Health Organization (WHO) to have advanced oversight […] Continue reading -> Uganda and WHO to Test Vaccine Candidates to Combat Country’s Ebola Outbreak 04/11/2022 Stefan Anderson On Friday, the Ebola taskforce of Kassanda district in Uganda delivered the remains of four people that succumbed to the the virus for burial to their home village of Kitongo. Three of the bodies belong to family members who died from exposure to the virus after they exhumed a loved one they had lost to […] Continue reading -> Gavi Undertakes to Change Vaccine Procurement to Support New African Manufacturers 03/11/2022 Kerry Cullinan Gavi, the global vaccine alliance, has undertaken to adapt its approach to procuring vaccines in order to support African vaccine manufacturing. In a plan released on Thursday, Gavi has committed to placing “a higher value on the benefits of diversification to supply security, with a focus on Africa”. The 10-point plan, developed in consultation with […] Continue reading -> Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> WHO’s African mRNA Hub to Begin Animal Trial on COVID Vaccine 05/10/2022 Megha Kaveri The mRNA Vaccine Technology Transfer Hub in South Africa will start animal studies on its first COVID-19 vaccine candidate in October, a senior World Health Organization official said Wednesday. If all goes according to plan, human clinical trials will begin towards the end of 2023. “We did start this (mRNA vaccine hub) with a longer […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
South Korea Becomes First Country to Achieve Highest Level in WHO’s Medicine And Vaccine Regulatory Assessment 01/12/2022 Megha Kaveri South Korea became the first country in the world to achieve the highest level, “maturity level 4” (ML4), in regulating medicines and vaccines. The Ministry of Food and Drug Safety (MFDS) in the Republic of Korea is the only national regulatory authority to be recognised by the World Health Organization (WHO) to have advanced oversight […] Continue reading -> Uganda and WHO to Test Vaccine Candidates to Combat Country’s Ebola Outbreak 04/11/2022 Stefan Anderson On Friday, the Ebola taskforce of Kassanda district in Uganda delivered the remains of four people that succumbed to the the virus for burial to their home village of Kitongo. Three of the bodies belong to family members who died from exposure to the virus after they exhumed a loved one they had lost to […] Continue reading -> Gavi Undertakes to Change Vaccine Procurement to Support New African Manufacturers 03/11/2022 Kerry Cullinan Gavi, the global vaccine alliance, has undertaken to adapt its approach to procuring vaccines in order to support African vaccine manufacturing. In a plan released on Thursday, Gavi has committed to placing “a higher value on the benefits of diversification to supply security, with a focus on Africa”. The 10-point plan, developed in consultation with […] Continue reading -> Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> WHO’s African mRNA Hub to Begin Animal Trial on COVID Vaccine 05/10/2022 Megha Kaveri The mRNA Vaccine Technology Transfer Hub in South Africa will start animal studies on its first COVID-19 vaccine candidate in October, a senior World Health Organization official said Wednesday. If all goes according to plan, human clinical trials will begin towards the end of 2023. “We did start this (mRNA vaccine hub) with a longer […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Uganda and WHO to Test Vaccine Candidates to Combat Country’s Ebola Outbreak 04/11/2022 Stefan Anderson On Friday, the Ebola taskforce of Kassanda district in Uganda delivered the remains of four people that succumbed to the the virus for burial to their home village of Kitongo. Three of the bodies belong to family members who died from exposure to the virus after they exhumed a loved one they had lost to […] Continue reading -> Gavi Undertakes to Change Vaccine Procurement to Support New African Manufacturers 03/11/2022 Kerry Cullinan Gavi, the global vaccine alliance, has undertaken to adapt its approach to procuring vaccines in order to support African vaccine manufacturing. In a plan released on Thursday, Gavi has committed to placing “a higher value on the benefits of diversification to supply security, with a focus on Africa”. The 10-point plan, developed in consultation with […] Continue reading -> Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> WHO’s African mRNA Hub to Begin Animal Trial on COVID Vaccine 05/10/2022 Megha Kaveri The mRNA Vaccine Technology Transfer Hub in South Africa will start animal studies on its first COVID-19 vaccine candidate in October, a senior World Health Organization official said Wednesday. If all goes according to plan, human clinical trials will begin towards the end of 2023. “We did start this (mRNA vaccine hub) with a longer […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gavi Undertakes to Change Vaccine Procurement to Support New African Manufacturers 03/11/2022 Kerry Cullinan Gavi, the global vaccine alliance, has undertaken to adapt its approach to procuring vaccines in order to support African vaccine manufacturing. In a plan released on Thursday, Gavi has committed to placing “a higher value on the benefits of diversification to supply security, with a focus on Africa”. The 10-point plan, developed in consultation with […] Continue reading -> Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> WHO’s African mRNA Hub to Begin Animal Trial on COVID Vaccine 05/10/2022 Megha Kaveri The mRNA Vaccine Technology Transfer Hub in South Africa will start animal studies on its first COVID-19 vaccine candidate in October, a senior World Health Organization official said Wednesday. If all goes according to plan, human clinical trials will begin towards the end of 2023. “We did start this (mRNA vaccine hub) with a longer […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> WHO’s African mRNA Hub to Begin Animal Trial on COVID Vaccine 05/10/2022 Megha Kaveri The mRNA Vaccine Technology Transfer Hub in South Africa will start animal studies on its first COVID-19 vaccine candidate in October, a senior World Health Organization official said Wednesday. If all goes according to plan, human clinical trials will begin towards the end of 2023. “We did start this (mRNA vaccine hub) with a longer […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> WHO’s African mRNA Hub to Begin Animal Trial on COVID Vaccine 05/10/2022 Megha Kaveri The mRNA Vaccine Technology Transfer Hub in South Africa will start animal studies on its first COVID-19 vaccine candidate in October, a senior World Health Organization official said Wednesday. If all goes according to plan, human clinical trials will begin towards the end of 2023. “We did start this (mRNA vaccine hub) with a longer […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> WHO’s African mRNA Hub to Begin Animal Trial on COVID Vaccine 05/10/2022 Megha Kaveri The mRNA Vaccine Technology Transfer Hub in South Africa will start animal studies on its first COVID-19 vaccine candidate in October, a senior World Health Organization official said Wednesday. If all goes according to plan, human clinical trials will begin towards the end of 2023. “We did start this (mRNA vaccine hub) with a longer […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> WHO’s African mRNA Hub to Begin Animal Trial on COVID Vaccine 05/10/2022 Megha Kaveri The mRNA Vaccine Technology Transfer Hub in South Africa will start animal studies on its first COVID-19 vaccine candidate in October, a senior World Health Organization official said Wednesday. If all goes according to plan, human clinical trials will begin towards the end of 2023. “We did start this (mRNA vaccine hub) with a longer […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO’s African mRNA Hub to Begin Animal Trial on COVID Vaccine 05/10/2022 Megha Kaveri The mRNA Vaccine Technology Transfer Hub in South Africa will start animal studies on its first COVID-19 vaccine candidate in October, a senior World Health Organization official said Wednesday. If all goes according to plan, human clinical trials will begin towards the end of 2023. “We did start this (mRNA vaccine hub) with a longer […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts